MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Home・Lista de Ações・CorMedix Inc

CorMedix Inc

Fechado

SetorSaúde

6.99 -1.27

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

6.9

Máximo

7.2

Indicadores-chave
By Trading Economics
Rendimento	89M 109M
Vendas	65M 104M
P/E Médio do Setor	3.235 90.831
Margem de lucro	104.112
Funcionários	64
EBITDA	37M 57M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+140.79% upside

Dividendos
By Dow Jones
Próximos Ganhos	24 de mar. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-305M 563M
Abertura anterior	8.26
Fecho anterior	6.99

Sentimento de Notícias

By Acuity

25%

75%

45 / 361 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

9.2 / N/A Suporte e Resistência

CorMedix Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de jan. de 2026, 18:44 UTC

Grandes Movimentos do Mercado

Agenus Falls After $141 Million Zydus Deal Closes

15 de jan. de 2026, 17:51 UTC

Grandes Movimentos do Mercado

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15 de jan. de 2026, 17:25 UTC

Grandes Movimentos do Mercado

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15 de jan. de 2026, 23:40 UTC

Conversa de Mercado

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15 de jan. de 2026, 23:11 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

15 de jan. de 2026, 23:11 UTC

Conversa de Mercado

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15 de jan. de 2026, 23:01 UTC

Conversa de Mercado

New Zealand's Economy Enters An Upswing -- Market Talk

15 de jan. de 2026, 22:56 UTC

Conversa de Mercado

Ganhos

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15 de jan. de 2026, 22:51 UTC

Conversa de Mercado

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15 de jan. de 2026, 22:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Ganhos

Financial Services Roundup: Market Talk

15 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Energy & Utilities Roundup: Market Talk

15 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

15 de jan. de 2026, 21:27 UTC

Ganhos

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15 de jan. de 2026, 21:15 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Global Commodities Roundup: Market Talk

15 de jan. de 2026, 21:11 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Global Equities Roundup: Market Talk

15 de jan. de 2026, 21:11 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15 de jan. de 2026, 20:10 UTC

Conversa de Mercado

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15 de jan. de 2026, 20:04 UTC

Ganhos

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15 de jan. de 2026, 20:03 UTC

Conversa de Mercado

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15 de jan. de 2026, 19:26 UTC

Conversa de Mercado

Silver Closes at Fresh High -- Market Talk

15 de jan. de 2026, 18:29 UTC

Grandes Movimentos do Mercado

Agenus Falls After $141M Zydus Deal Closes

15 de jan. de 2026, 18:20 UTC

Ganhos

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15 de jan. de 2026, 17:56 UTC

Conversa de Mercado

Ganhos

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Auto & Transport Roundup: Market Talk

15 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

15 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

15 de jan. de 2026, 17:02 UTC

Aquisições, Fusões, Aquisições de Empresas

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Comparação entre Pares

Variação de preço

CorMedix Inc Previsão

Preço-alvo

By TipRanks

140.79% parte superior

Previsão para 12 meses

Média 17 USD 140.79%

Máximo 22 USD

Mínimo 14 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para CorMedix Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

Comprar

Manter

Vender

Com base em 6 analistas que deram avaliações de ações para CorMedix Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

9.2 / N/ASuporte e Resistência

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimento

By Acuity

45 / 361 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.